✨ Your Portfolio is fetched and updated from zerodha.
Small Pharmaceuticals
Market Cap
₹4,934 Cr.
P/E
0.00

Key Ratios

Market cap
Market cap
4,934 Cr
PE
PE
-
Prom Holding
Prom Holding
57.42 %
ROE (%)
ROE (%)
-25.21
ROCE (%)
ROCE (%)
-14.21
Div Yield (%)
Div Yield (%)
0.06
Sales
Sales
401 Cr
OPM (%)
OPM (%)
1.66 %
Debt to Equity
Debt to Equity
0.03

About

Zota Health Care is a pharmaceutical company that develops, manufactures, and markets generic,… Read more
Low
535
52W Range
High
1614
  • Zota Health Care
  • Guj. Themis Biosyn
  • Sequent Scientific

Timeline

Dividend Update Board Meeting Financials

Key company specific updates

Custom financial statement

New
Edit rows

Forensics

9 Yes

Positive for this company

2 Neutral

Neutral for this company

4 No

Negative for this company

2 No Data

Insufficient data to analyse

Revenue mix

Product Wise Break-Up

Location Wise Break-Up

Operational Metrics

    Select a Metric
    • Number of Stores - Franchises (.)
    • Number of Stores (.)
    • Number of Stores - Company Owned (.)
    • Average Revenue Per User (ARPU) (Rs)
    • R&D as a % of Total Sales (%)

    Peer Comparison

    Corporate Actions

    Consolidated
    DATE
    DETAILS
    Show More
    Show Less
    Show More
    Show Less

    FAQs on Zota Health Care Ltd. Business

    Zota Health Care is a pharmaceutical company that develops, manufactures, and markets generic, patented, and OTC pharmaceutical products in India and internationally through its distributor network.

    Zota Health Care major competitors are Guj. Themis Biosyn, Sequent Scientific, Orchid Pharma, Gufic Biosciences, Unichem Lab, Panacea Biotec, Indoco Remedies.
    Market Cap of Zota Health Care is ₹4,934 Crs.
    While the median market cap of its peers are ₹3,502 Crs.

    Zota Health Care seems to be financially stable compared to its competitors.
    The probability of it going bankrupt or facing a financial crunch seem to be lower than its immediate competitors.

    Company Filing

    2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010
    Annual Report FY25 FY24 FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16 FY15 FY14 FY13 FY12 FY11 FY10
    Earnings Release
    Investor Presentation Mar Jun Sep Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Jun Dec
    Conference Call
    Conference Call SummaryCon Call Summary

    Discussions & Analysis

    Ideas Dashboard
    Results
    Timeline
    Watchlist
    Portfolio
    Alerts
    Stock Screener
    Market
    Raw Material